Pulse Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $832 | $1,664 | $0 |
Gross Profit | -267 | -283 | 832 | -267 |
EBITDA | -18,901 | -18,044 | -19,974 | -13,361 |
EBIT | -19,168 | -18,327 | -20,261 | -13,655 |
Net Income | -19,168 | -16,795 | -19,385 | -12,680 |
Net Change In Cash | 0 | 832 | 1,664 | 0 |
Free Cash Flow | -12,910 | -13,566 | -9,197 | -9,062 |
Cash | 106,349 | 119,279 | 118,038 | 79,033 |
Basic Shares | 67,276 | 67,126 | 58,398 | 61,066 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $-9 | $700 | $1,418 |
Gross Profit | -1,178 | -1,207 | -11,244 | -550 |
EBITDA | -52,407 | -42,367 | -56,702 | -61,868 |
EBIT | -53,585 | -43,574 | -58,057 | -63,014 |
Net Income | -53,585 | -42,210 | -58,953 | -63,160 |
Net Change In Cash | 0 | -9 | 700 | 1,418 |
Free Cash Flow | -36,468 | -33,162 | -47,414 | -54,534 |
Cash | 118,038 | 44,365 | 61,139 | 28,614 |
Basic Shares | 58,398 | 48,038 | 33,935 | 27,964 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.28 |
2025-03-31 | -$0.25 |
2024-12-31 | -$0.31 |
2024-09-30 | -$0.20 |
